Skip to content

ePlus PLUS Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number

Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number at other companies

Repligen logo
RepligenRGEN
116.8K
The Baldwin Insurance Group, Inc. logo
The Baldwin Insurance Group, Inc.BWIN
1.7M+57.1%
Mondelez International logo
Mondelez InternationalMDLZ
6.6M+14.8%
Repligen logo
RepligenRGEN
567K
Cal-Maine Foods logo
Cal-Maine FoodsCALM
529-74.3%
WSFS Financial logo
WSFS FinancialWSFS
0-100%

Other financials

Income statement

See full
Revenue$581.6M+21.7%
Gross profit$147.1M+10.7%
Operating income$37.6M+52.0%
Net income$25.0M+14.9%
EPS (diluted)$0.95+14.5%

Balance sheet

See full
Cash & equivalents$410.8M+5.5%
Total debt$16.3M-80.9%
Total equity$1.1B+10.1%
Total assets$1.8B-4.2%

Cash flow

See full
Operating cash flow-$87.4M-233%
CapEx$1.2M-36.5%
Free cash flow-$30.2M-119%

Valuation

See full
Market cap$2.11B+22.3%

Profitability

See full
Gross margin25.2%-0.4pp
Operating margin6.8%+1.8pp
Net margin5.4%+0.2pp
FCF margin-10.4%-26.4pp

Returns & leverage

See full
Return on equity13%+1.8pp
Debt / equity-0.1×
Current ratio2.2×+0.5×

Where this comes from

Reported directly by ePlus in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.

The official record: ePlus’s 10-Q, filed February 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about ePlus's share based compensation arrangement by share based payment award equity instruments other than options nonvested number.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ePlus's share based compensation arrangement by share based payment award equity instruments other than options nonvested number?
ePlus (PLUS) reported share based compensation arrangement by share based payment award equity instruments other than options nonvested number of $72.63K in Q4 2025.